Mwg-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "PRME",
  "LYEL",
  "BEAM"
]

13F-HR • 2025-03-31

Data Enrichment

100% identified

3 identified0 unidentified

Holdings

Manager:

3 positions • $58.7M total value

Manager:

Search and click to pin securities to the top

Sort by:

Beam Therapeutics Inc.

Shares:2.3M

Value:$44.3M

% of Portfolio:75.4% ($44.3M/$58.7M)

Lyell Immunopharma, Inc.

Shares:20.2M

Value:$10.8M

% of Portfolio:18.5% ($10.8M/$58.7M)

Prime Medicine, Inc.

Shares:1.8M

Value:$3.6M

% of Portfolio:6.1% ($3.6M/$58.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Beam Therapeutics Inc.(BEAMcusip07373V105)	2.3M	QoQ 0.00% (-0) YoY -3.40% (-80.0K)	All Managers (Combined)	$44.3M	75.4% ($44.3M/$58.7M)	QoQ -21.24% (-$11.9M) YoY -42.90% (-$33.3M)
Lyell Immunopharma, Inc.(LYELcusip55083R104)	20.2M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$10.8M	18.5% ($10.8M/$58.7M)	QoQ -15.93% (-$2.1M) YoY -75.87% (-$34.1M)
Prime Medicine, Inc.(PRMEcusip74168J101)	1.8M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$3.6M	6.1% ($3.6M/$58.7M)	QoQ -31.84% (-$1.7M) YoY -71.57% (-$9.0M)